Panstay-DSR contains 40mg of Pantoprazole along with 30mg Domperidone. These are sustained release capsules belonging to Proton pump inhibitor class of antacid drugs. It's a product of Brenstem Biosciences with attractive packing and highly efficient results.
Panstay-DSR Contraindications
Get link
Facebook
X
Pinterest
Email
Other Apps
Patients
with known allergies to Domperidone.
Pregnancy
Use
with caution in children except in cancer chemotherapy.
For purchase and sale of Panstay-DSR, please contact Brenstem Biosciences at +91-9988444900 or brenstem@gmail.com Available for franchisee on monopoly rights as well as contract manufacturing facility is also available.
Powerful synergistic combination for faster healing GERD and erosive esophagitis. Rapid and lasting reduction in acid production. Increases lower esophageal tone and esophageal clearance. Round the clock relief from GERD in lower dose due to sustained release dosage form. Convenience once daily dose increases compliance. More effective in 24-hour intragastric pH profiles than Omeprazole. Low potential to interact with the cytochrome P450 enzyme system. Steady state serum concentration.
1) Very rarely extrapyramidal syndrome - e.g. Parkinsonism, tardive dyskinesia. 2) Domperidone may cause galactorrhoea and gynaecomastia due to Hyperprolactinaemia 3) Other minor side effects Dry mouth, thirst Headache Nervousness Diarrhea Skin rash, itching Increase in TSH level, hypothyroid woman.
Comments
Post a Comment